mRNA-1273 vaccine-induced antibodies maintain Fc effector functions across SARS-CoV-2 variants of concern
Paulina Kapłonek, Stephanie Fischinger, Deniz Cizmeci, Yannic C. Bartsch, Jaewon Kang, John S. Burke, Sally Shin, Diana Dayal, Patrick Martin, Colin Mann, Fatima Amanat, Boris Jülg, Eric J. Nilles, Elon R. Musk, Anil Menon, Florian Krammer, E.O. Saphire, Andrea Carfı́, Galit Alter
Topics & Concepts
NeutralizationAntibodyBiologyEffectorVirologyNeutralizing antibodyImmunologyImmune systemReceptorImmunitySevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Messenger RNACoronavirus disease 2019 (COVID-19)DiseaseInfectious disease (medical specialty)GeneMedicineGeneticsPathologySARS-CoV-2 and COVID-19 ResearchMonoclonal and Polyclonal Antibodies ResearchAnimal Virus Infections Studies